Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Pharma

AstraZeneca Wins Two Approval Recommendations From EU Agency

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Forxiga for treating a form of heart failure and Trixeo Aerosphere for a form of lung disorder known as "smoker's lung".

Read More

E-Pharmacy players fall short on customer expectations in digital experience: Ipsos E-Pharmacy Digital Audit

The study was a mystery shopping study conducted among top e-pharmacy players to measure end-to-end journey, including major touch points.

Read More

J&J Pauses Coronavirus Vaccine Trials Due To Unexplained Illness

The move comes around a month after AstraZeneca also suspended trials of its experimental coronavirus vaccine - which uses a similar technology - due to a participant falling ill.

Read More

Prescriptions for E-Pharmacy

De-coupling legality from sectoral hygiene can provide necessary certainty to entrepreneurs to invest and take risks. It also reduces the need for judicial intervention that can stymie new markets.

Read More

Zydus Cadila Gets Tentative USFDA Nod To Market Anti-cancer Drug

The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.

Read More

Zydus Cadila Gets USFDA Nod To Market Mineral Supplement

The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the special economic zone (SEZ), Ahmedabad.

Read More

Multiple Challenges Crippling Healthcare in India: Sangita Reddy

The hospitals that were already financially fragile over the past few years have been stressed with the unplanned investments for COVID-19 preparedness and response; and have seen their revenues topple due to a 60-80 per cent decline in patient footfalls, leading to estimated operational losses of Rs 4500 crore per month

Read More

Safety First

The Covid-19 vaccine candidate Covaxin, developed by ICMR and Bharat Biotech, is currently in Phase I/II human trials and is being tested at 12 institutes across India.

Read More

Telemedicine Market In India To Reach $5.5 Bn by 2025: EY-IPA study

Virtual care consists of tele–consult, telepathology, teleradiology and e–pharmacy and is experiencing an encouraging stimulus in India due to the pandemic

Read More

Healthcare Is Now Getting The Attention It Deserves: GSK Velu, Chairman & Managing Director, Trivitron Healthcare

Today, most people prefer getting blood tests done from home. And now we are offering even ECGs at home. X-rays too can be done at home. This trend will only increase

Read More

Sanofi, GSK Launch Trial For COVID-19 Protein-based Vaccine

If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.

Read More

Zydus Cadila Gets USFDA Nod For Muscle Relaxant Injection

The group now has 297 approvals and has so far filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Read More

Moderna COVID-19 Vaccine Appears To Work As Well In Older Adults In Early Study

Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines.

Read More

India Approves Avigan (Favipiravir) for COVID-19 Treatment

In India, GRA and Dr. Reddy’s will look to distribute Avigan® through private healthcare providers opting for a premium quality drug. The initial supply will contain the original Avigan®, made in Japan.

Read More

RIL Arm Acquires Majority Stake In Online Pharmacy Netmeds For Rs 620 Cr

E-pharmacies is a large market in India and the retail segment is a fragmented one, ripe for consolidation.

Read More